0
     

Report Added
Report already added
Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) - Global Forecast to 2026

Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) - Global Forecast to 2026

The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

“By instruments segment, the imagers sub segment accounted for the fastest-growing segment of the western blotting market”

Based on instruments, the western blotting market is segmented into gel electrophoresis instruments, blotting systems, and imagers. Growth in this product segment is primarily due to the automation of imagers, which simplifies the protein detection process.

“By end user segment, the academic & research institutes segment accounted for the largest share of the western blotting market”

Based on end users, the western blotting market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users In 2020, academic & research institutes accounted for the largest share of the western blotting market. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.

“Asia Pacific: The fastest-growing region in the western blotting market.”

The western blotting market in the Asia Pacific region is projected to register the highest growth during the forecast period. The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bioclusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.

“North America: the largest share of the western blotting market”

In 2020, North America accounted for the largest share of the western blotting market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
•By Respondent– Supply Side- 70%, Demand Side-30%
•By Designation— CXOs and Directors- 30%, Executives - 25%, Mangers - 45%
•By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10% , MEA- 5%

Prominent players in the western blotting market include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bio-Techne Corporation (US), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Advansta Inc. (US), Cell Signaling Technology, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Azure Biosystems, Inc. (US), Boster Biological Technology (US), Geno Technology Inc. (US), Rockland Immunochemicals, Inc. (US), Precision Biosystems (US), Cleaver Scientific Ltd. (UK), Abcam Plc (UK), Proteintech Group (US), Enzo Biochem, Inc. (US), Abnova Corporation (Taiwan), Sino Biological Inc. (China), StressMarq Biosciences Inc. (Canada), Abbexa Ltd. (UK), Covalab S.A.S. (France), and Biorbyt Ltd. (UK).

Research Coverage:

The report segments the western blotting market based on region (the Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa), product (consumables [Reagents & Buffers, Antibodies & Conjugates {Primary Antibodies, Secondary Antibodies, Other Antibodies & Conjugates}, Kits

Membranes & Filter Papers Other Consumables], instruments [Electrophoresis, Blotting Systems {Semi-dry Blotting Systems, Wet Blotting Systems}, Imagers {Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers}]), application (Biomedical Research, Clinical Diagnostics [HIV, Lyme Disease, Hepatitis, Other Diseases], Agricultural Applications, Other Applications), and end-user (Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the western blotting market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the western blotting market and provides them information on key market drivers, restraints, challenges, and opportunities.
1INTRODUCTION41
1.1OBJECTIVES OF THE STUDY41
1.2MARKET DEFINITION42
1.2.1INCLUSIONS & EXCLUSIONS42
1.3MARKET SCOPE43
1.3.1MARKETS COVERED43
FIGURE 1WESTERN BLOTTING MARKET SEGMENTATION43
1.3.2YEARS CONSIDERED FOR THE STUDY43
1.4CURRENCY44
1.5LIMITATIONS44
1.6STAKEHOLDERS44
1.7SUMMARY OF CHANGES45
2RESEARCH METHODOLOGY46
2.1RESEARCH DATA46
FIGURE 2RESEARCH DESIGN46
2.1.1SECONDARY DATA46
2.1.2PRIMARY DATA47
FIGURE 3PRIMARY SOURCES48
FIGURE 4WESTERN BLOTTING MARKET: BREAKDOWN OF PRIMARIES48
2.1.2.1Key industry insights49
2.2MARKET SIZE ESTIMATION50
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 202050
FIGURE 6MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL WESTERN BLOTTING PRODUCTS50
FIGURE 7WESTERN BLOTTING MARKET: CAGR PROJECTIONS, 2021–202652
FIGURE 8WESTERN BLOTTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES52
2.3MARKET BREAKDOWN AND DATA TRIANGULATION54
FIGURE 9DATA TRIANGULATION METHODOLOGY54
2.4RESEARCH LIMITATIONS55
2.5GROWTH RATE ASSUMPTIONS55
2.6RISK ANALYSIS56
3EXECUTIVE SUMMARY57
FIGURE 10WESTERN BLOTTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)57
FIGURE 11WESTERN BLOTTING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)58
FIGURE 12WESTERN BLOTTING MARKET SHARE, BY END USER, 202058
FIGURE 13GEOGRAPHICAL SNAPSHOT OF THE WESTERN BLOTTING MARKET59
4PREMIUM INSIGHTS60
4.1WESTERN BLOTTING MARKET OVERVIEW60
FIGURE 14TECHNOLOGICAL ADVANCEMENTS AND GROWING DEMAND FOR PERSONALIZED MEDICINE ARE KEY FACTORS DRIVING GROWTH IN
THE WESTERN BLOTTING MARKET60
4.2ASIA PACIFIC: WESTERN BLOTTING MARKET, BY END USER & COUNTRY (2020)61
FIGURE 15ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 202061
4.3WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 202061
FIGURE 16THE BLOTTING SYSTEMS SEGMENT DOMINATED THE MARKET IN 202061
4.4WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 202062
FIGURE 17THE SEMI-DRY BLOTTING SYSTEMS SEGMENT IS PROJECTED TO WITNESS
THE HIGHEST GROWTH DURING THE FORECAST PERIOD62
4.5WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 202062
FIGURE 18THE CHEMILUMINESCENT IMAGERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE WESTERN BLOTTING MARKET IN 202062
5MARKET OVERVIEW63
5.1INTRODUCTION63
5.2MARKET DYNAMICS63
FIGURE 19WESTERN BLOTTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES63
5.2.1DRIVERS64
5.2.1.1Technological advancements64
5.2.1.2Increasing government funding in the field of biomedical research64
5.2.1.3Growing demand for personalized medicine65
FIGURE 20NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–202065
5.2.1.4Rising global prevalence and incidence of HIV/AIDS66
TABLE 1INCIDENCE OF HIV/AIDS, BY REGION, 202066
5.2.2RESTRAINTS67
5.2.2.1Emergence of alternative technologies67
5.2.3OPPORTUNITIES67
5.2.3.1Emerging economies67
5.2.4CHALLENGES68
5.2.4.1Requirement of high procedural efficiency for accurate results68
5.3IMPACT OF COVID-19 ON THE WESTERN BLOTTING MARKET69
5.4PATENT ANALYSIS70
5.4.1NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS70
5.4.2TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS70
5.4.3TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS71
5.4.4LIST OF RECENT PATENTS71
5.5REGULATORY GUIDELINES72
5.5.1NORTH AMERICA72
5.5.2EUROPE72
5.5.3EMERGING MARKETS72
5.6VALUE CHAIN ANALYSIS73
FIGURE 21VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES73
5.7SUPPLY CHAIN ANALYSIS74
FIGURE 22DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES75
5.8PORTER’S FIVE FORCES ANALYSIS75
TABLE 2WESTERN BLOTTING MARKET: PORTER’S FIVE FORCES ANALYSIS75
5.8.1DEGREE OF COMPETITION75
5.8.2BARGAINING POWER OF SUPPLIERS76
5.8.3BARGAINING POWER OF BUYERS76
5.8.4THREAT FROM SUBSTITUTES76
5.8.5THREAT FROM NEW ENTRANTS76
5.9ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET77
FIGURE 23ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET77
5.9.1ROLE IN THE ECOSYSTEM77
5.10TECHNOLOGY ANALYSIS78
5.10.1ALTERNATIVES TO TRADITIONAL WESTERN BLOTTING78
5.11RANGES/SCENARIOS79
FIGURE 24DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE WESTERN BLOTTING MARKET79
5.12TRADE ANALYSIS80
5.12.1TRADE ANALYSIS FOR WESTERN BLOTTING80
TABLE 3IMPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION)80
TABLE 4EXPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION)80
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS81
6WESTERN BLOTTING MARKET, BY PRODUCT82
6.1INTRODUCTION83
TABLE 5WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)83
6.2CONSUMABLES83
TABLE 6WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)83
TABLE 7WESTERN BLOTTING CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION)84
TABLE 8NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)84
TABLE 9EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)84
TABLE 10APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)85
6.2.1REAGENTS & BUFFERS85
6.2.1.1High consumption of reagents & buffers during the western blot process to drive market growth85
TABLE 11WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY REGION, 2019–2026 (USD MILLION)86
TABLE 12NORTH AMERICA: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019–2026 (USD MILLION)86
TABLE 13EUROPE: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION)87
TABLE 14APAC: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION)87
6.2.2ANTIBODIES & CONJUGATES87
TABLE 15WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)87
TABLE 16WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY REGION, 2019–2026 (USD MILLION)88
TABLE 17NORTH AMERICA: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)88
TABLE 18EUROPE: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION)88
TABLE 19APAC: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION)89
6.2.2.1Primary antibodies89
6.2.2.1.1Primary antibodies are mainly used to recognize a specific protein of interest89
TABLE 20WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY REGION,
2019–2026 (USD MILLION)89
TABLE 21NORTH AMERICA: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION)90
TABLE 22EUROPE: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)90
TABLE 23APAC: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)90
6.2.2.2Secondary antibodies91
6.2.2.2.1High sensitivity of secondary antibodies makes it easier to detect proteins of interest in complex protein mixtures91
TABLE 24WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019–2026 (USD MILLION)91
TABLE 25NORTH AMERICA: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION)91
TABLE 26EUROPE: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)92
TABLE 27APAC: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION)92
6.2.2.3Other antibodies & conjugates92
TABLE 28WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES,
BY REGION, 2019–2026 (USD MILLION)93
TABLE 29NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)93
TABLE 30EUROPE: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)93
TABLE 31APAC: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION)94
6.2.3KITS94
6.2.3.1Repeat purchases of single-use ready-to-use kits to drive market growth94
TABLE 32WESTERN BLOTTING MARKET FOR KITS, BY REGION,
2019–2026 (USD MILLION)94
TABLE 33NORTH AMERICA: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019–2026 (USD MILLION)95
TABLE 34EUROPE: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION)95
TABLE 35APAC: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION)95
6.2.4MEMBRANES & FILTER PAPERS96
6.2.4.1Extensive usage of membranes & filter papers to support the immobilization and transfer steps during western blotting experiments to drive market growth96
TABLE 36COMPARISON OF NITROCELLULOSE MEMBRANES AND PVDF MEMBRANES96
TABLE 37WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY REGION, 2019–2026 (USD MILLION)97
TABLE 38NORTH AMERICA: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION)97
TABLE 39EUROPE: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION)97
TABLE 40APAC: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY COUNTRY, 2019–2026 (USD MILLION)98
6.2.5OTHER CONSUMABLES98
TABLE 41WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019–2026 (USD MILLION)98
TABLE 42NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 43EUROPE: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 44APAC: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION)99
6.3INSTRUMENTS100
TABLE 45WESTERN BLOTTING INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION)100
TABLE 46NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)100
TABLE 47EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)101
TABLE 48APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)101
TABLE 49WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)101

6.3.1GEL ELECTROPHORESIS INSTRUMENTS102
6.3.1.1Increased demand for 2D electrophoresis due to its high separation performance is one of the major factors driving the growth of
the market102
TABLE 50WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)102
TABLE 51NORTH AMERICA: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)103
TABLE 52EUROPE: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)103
TABLE 53APAC: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)103
6.3.2BLOTTING SYSTEMS104
TABLE 54COMPARISON BETWEEN PROTEIN BLOTTING SYSTEMS104
TABLE 55WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY TYPE,
2019–2026 (USD MILLION)104
TABLE 56WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY REGION,
2019–2026 (USD MILLION)105
TABLE 57NORTH AMERICA: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)105
TABLE 58EUROPE: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)105
TABLE 59APAC: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)106
6.3.2.1Wet blotting systems106
6.3.2.1.1Wet systems are most commonly used for the transfer of proteins from gels to membranes106
TABLE 60WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION)106
TABLE 61NORTH AMERICA: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)107
TABLE 62EUROPE: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)107
TABLE 63APAC: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)107
6.3.2.2Semi-dry blotting systems108
6.3.2.2.1Minimal usage of buffers during the process and rapid transfer of proteins from gels to membranes are major factors driving the demand for semi-dry blotting systems108
TABLE 64WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION)108
TABLE 65NORTH AMERICA: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)108
TABLE 66EUROPE: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)109
TABLE 67APAC: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION)109

6.3.3IMAGERS109
TABLE 68WESTERN BLOTTING MARKET FOR IMAGERS, BY TYPE,
2019–2026 (USD MILLION)110
TABLE 69WESTERN BLOTTING MARKET FOR IMAGERS, BY REGION,
2019–2026 (USD MILLION)110
TABLE 70NORTH AMERICA: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)110
TABLE 71EUROPE: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION)111
TABLE 72APAC: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION)111
6.3.3.1Chemiluminescent imagers111
6.3.3.1.1Low cost of these imagers, easy handling, and sensitivity are some of the key factors contributing to the large share of this market111
TABLE 73WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY REGION, 2019–2026 (USD MILLION)112
TABLE 74NORTH AMERICA: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)112
TABLE 75EUROPE: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)112
TABLE 76APAC: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)113
6.3.3.2Fluorescent imagers113
6.3.3.2.1Fluorescent imagers serve as one-stop imaging systems as they avoid multiple film exposures and development steps113
TABLE 77WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY REGION, 2019–2026 (USD MILLION)113
TABLE 78NORTH AMERICA: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)114
TABLE 79EUROPE: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)114
TABLE 80APAC: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)114
6.3.3.3Other imagers115
TABLE 81WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY REGION,
2019–2026 (USD MILLION)115
TABLE 82NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION)115
TABLE 83EUROPE: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)116
TABLE 84APAC: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION)116

7WESTERN BLOTTING MARKET, BY APPLICATION117
7.1INTRODUCTION118
TABLE 85WESTERN BLOTTING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)118
7.2BIOMEDICAL RESEARCH118
7.2.1INCREASING RESEARCH FUNDING FOR PROTEOMICS AND PROTEIN-BASED RESEARCH—A MAJOR DRIVER FOR THIS APPLICATION SEGMENT118
TABLE 86WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)119
TABLE 87NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)119
TABLE 88EUROPE: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)119
TABLE 89APAC: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)120
7.3CLINICAL DIAGNOSTICS120
TABLE 90WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION)120
TABLE 91NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)121
TABLE 92EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)121
TABLE 93APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)121
TABLE 94WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY DISEASE TYPE, 2019–2026 (USD MILLION)122
7.3.1HIV122
7.3.1.1Western blotting is the most widely used method for HIV diagnosis—
a key factor driving market growth122
TABLE 95WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION)122
TABLE 96NORTH AMERICA: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)123
TABLE 97EUROPE: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)123
TABLE 98APAC: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)123
7.3.2HEPATITIS124
7.3.2.1Growing incidence of hepatitis C to drive market growth124
TABLE 99WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION)124
TABLE 100NORTH AMERICA: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)124
TABLE 101EUROPE: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)125
TABLE 102APAC: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)125

7.3.3LYME DISEASE125
7.3.3.1Western blots are generally considered the most reliable tests currently available for Lyme disease diagnosis125
TABLE 103WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY REGION, 2019–2026 (USD MILLION)126
TABLE 104NORTH AMERICA: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION)126
TABLE 105EUROPE: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)126
TABLE 106APAC: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION)127
7.3.4OTHER DISEASES127
TABLE 107WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY REGION,
2019–2026 (USD MILLION)127
TABLE 108NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION)128
TABLE 109EUROPE: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)128
TABLE 110APAC: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)128
7.4AGRICULTURAL APPLICATIONS129
7.4.1GROWING CULTIVATION OF GENETICALLY MODIFIED CROPS TO DRIVE MARKET GROWTH129
TABLE 111WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION)129
TABLE 112NORTH AMERICA: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)129
TABLE 113EUROPE: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)130
TABLE 114APAC: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)130
7.5OTHER APPLICATIONS130
TABLE 115WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)131
TABLE 116NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)131
TABLE 117EUROPE: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)131
TABLE 118APAC: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)132
8WESTERN BLOTTING MARKET, BY END USER133
8.1INTRODUCTION134
TABLE 119WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION)134
8.2ACADEMIC & RESEARCH INSTITUTES134
8.2.1INCREASING GOVERNMENT INVESTMENTS FOR RESEARCH ACTIVITIES TO DRIVE GROWTH IN THIS MARKET SEGMENT134
TABLE 120WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION)135
TABLE 121NORTH AMERICA: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)135
TABLE 122EUROPE: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)135
TABLE 123APAC: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)136
8.3BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES136
8.3.1GROWING DRUG DISCOVERY AND CLINICAL STUDIES TO DRIVE THE DEMAND FOR WESTERN BLOTTING IN THE PHARMA-BIOTECH INDUSTRY136
TABLE 124WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)137
TABLE 125NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)137
TABLE 126EUROPE: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)137
TABLE 127APAC: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)138
8.4HOSPITALS & DIAGNOSTIC LABORATORIES138
8.4.1GROWING PATIENT POPULATION AND TESTING VOLUMES TO DRIVE MARKET GROWTH138
TABLE 128WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)139
TABLE 129NORTH AMERICA: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)139
TABLE 130EUROPE: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)140
TABLE 131APAC: WESTERN BLOTTING FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)140
8.5OTHER END USERS140
TABLE 132WESTERN BLOTTING MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION)141
TABLE 133NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION)141
TABLE 134EUROPE: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION)141
TABLE 135APAC: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)142
9WESTERN BLOTTING MARKET, BY REGION143
9.1INTRODUCTION144
9.2NORTH AMERICA144
FIGURE 25NORTH AMERICA: WESTERN BLOTTING MARKET SNAPSHOT144
TABLE 136NORTH AMERICA: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)145
TABLE 137NORTH AMERICA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)145
TABLE 138NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)145
TABLE 139NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)145
TABLE 140NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)146
TABLE 141NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)146
TABLE 142NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)146
TABLE 143NORTH AMERICA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)147
TABLE 144NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)147
TABLE 145NORTH AMERICA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)147
9.2.1US148
9.2.1.1The US dominates the North American western blotting market148
TABLE 146US: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)148
TABLE 147US: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)148
TABLE 148US: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)149
TABLE 149US: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)149
TABLE 150US: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)149
TABLE 151US: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)150
TABLE 152US: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)150
TABLE 153US: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)150
TABLE 154US: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION)151
9.2.2CANADA151
9.2.2.1Strong infrastructure and availability of funding for biomedical research to support market growth in Canada151
TABLE 155CANADA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)152
TABLE 156CANADA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)152
TABLE 157CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)152
TABLE 158CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)152
TABLE 159CANADA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)153
TABLE 160CANADA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)153
TABLE 161CANADA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)153
TABLE 162CANADA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)154
TABLE 163CANADA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)154
9.3EUROPE154
TABLE 164EUROPE: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)155
TABLE 165EUROPE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)155
TABLE 166EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)155
TABLE 167EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)156
TABLE 168EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)156
TABLE 169EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)156
TABLE 170EUROPE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)157
TABLE 171EUROPE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)157
TABLE 172EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)157
TABLE 173EUROPE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)158
9.3.1GERMANY158
9.3.1.1Germany is the largest market for western blotting in Europe158
TABLE 174GERMANY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)159
TABLE 175GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)159
TABLE 176GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)159
TABLE 177GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS MARKET, BY TYPE, 2019–2026 (USD MILLION)160
TABLE 178GERMANY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)160
TABLE 179GERMANY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)160
TABLE 180GERMANY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)161
TABLE 181GERMANY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)161
TABLE 182GERMANY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)161

9.3.2FRANCE162
9.3.2.1Proteomics research in France is strongly supported
by the government—a key factor driving market growth162
TABLE 183FRANCE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)162
TABLE 184FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)163
TABLE 185FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)163
TABLE 186FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION)163
TABLE 187FRANCE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)164
TABLE 188FRANCE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)164
TABLE 189FRANCE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)164
TABLE 190FRANCE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)165
TABLE 191FRANCE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)165
9.3.3UK165
9.3.3.1Government support for disease diagnostics and the favorable investment scenario to drive the market in the UK165
TABLE 192UK: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)166
TABLE 193UK: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)166
TABLE 194UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)167
TABLE 195UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)167
TABLE 196UK: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)167
TABLE 197UK: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)168
TABLE 198UK: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)168
TABLE 199UK: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)168
TABLE 200UK: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION)169
9.3.4ITALY169
9.3.4.1Growth in this market is mainly driven by increasing life science R&D in the country169
TABLE 201ITALY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)170
TABLE 202ITALY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)170
TABLE 203ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)170
TABLE 204ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)171
TABLE 205ITALY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)171
TABLE 206ITALY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)171
TABLE 207ITALY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)172
TABLE 208ITALY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)172
TABLE 209ITALY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)172
9.3.5SPAIN173
9.3.5.1Well-established network for translational medicine research to drive market growth in Spain173
TABLE 210SPAIN: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)173
TABLE 211SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)174
TABLE 212SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION)174
TABLE 213SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION)174
TABLE 214SPAIN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)175
TABLE 215SPAIN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION)175
TABLE 216SPAIN: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION)175
TABLE 217SPAIN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION)176
TABLE 218SPAIN: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION)176
9.3.6REST OF EUROPE (ROE)176
TABLE 219ROE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION)177
TABLE 220ROE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)177

Report Title: Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) - Global Forecast to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW